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Several genetic loci have been associated with risk of Achilles tendon pathology (ATP) within South 
African and Australian populations. The aim of this study was, therefore, to evaluate eight previously 
implicated genetic variants in an independent British population. A total of 130 asymptomatic controls 
(CON) and 112 participants clinically diagnosed with ATP comprising 87 individuals with chronic Achilles 
tendinopathy (TEN) and 25 with Achilles tendon ruptures (RUP) were included. All participants were 
genotyped for variants within the COL5A1, MIR608, IL-1β, IL-6 and CASP8 genes. Primary findings 
implicated COL5A1 and CASP8. Three inferred allele combinations constructed from COL5A1 rs12722, 
rs3196378 and rs71746744 were identified as risk modifiers. The T–C–D combination was associated 
with increased risk of ATP (P = 0.023) and RUP (P < 0.001), the C–A–I combination was associated with 
increased risk of ATP (P = 0.011), TEN (P = 0.011) and RUP (P = 0.011) and the C–C–D combination 
was associated with decreased risk of ATP (P = 0.011) and RUP (P = 0.004). The CASP8 rs3834129 DD 
genotype was associated with decreased risk of TEN (P = 0.020, odds ratio: 0.45, 95% confidence 
interval: 0.22–0.90) and the CASP8 I–G (rs3834129–rs1045485) inferred allele combination was 
associated with increased risk of TEN (P = 0.031). This study further highlights the importance of poly-




Achilles tendon pathology (ATP) is an encompassing term describing both chronic Achilles tendinopathy 
(TEN)  and acute Achilles tendon ruptures (RUPs), which are common among athletes (reviewed in 
Järvinen, Kannus, Maffulli,  & Khan, 2005). Both pathologies are multifactorial and influenced by both 
extrinsic and intrinsic risk factors, where an individual’s genetic profile has been identified as one of 
several intrinsic risk factors (Collins, September, & Posthumus, 2015; Meeuwisse, 1994). 
 
Several loci have been characterised in the aetiology of ATP based on the hypothesis that sequence 
variants may alter the tendon extracellular matrix (ECM) structure and/or regulation, thereby modifying 
ATP susceptibility (reviewed in Collins et al., 2015). Implicated genes include: COL5A1, which encodes 
the α1 chains of the heterotrimeric type V collagen and regulates collagen fibrillogenesis (Wenstrup et 
al., 2004); MIR608, which encodes, the micro-RNA, Hsa-miR-608 and may influence fibrillogenesis via 
its post-transcriptional regulation of COL5A1 and other ECM mRNAs (Abrahams, Laguette, Prince, & 
Collins, 2013); and the ECM regulators IL-1B, IL-6 and CASP8 which encode interleukin-1B (IL-1β), 
interleukin-6 (IL-6), and caspase-8 (CASP-8) and operate in overlapping cell signalling and apoptosis 
pathways (Nell et al., 2012; September et al., 2011) with the aim to maintain ECM homeostasis in 
response to mechanical stimuli (Riley, 2005; Yuan, Murrell, Wei, & Wang, 2002). 
 
These genes function collectively in interdependent relationships thereby potentially influencing the 
balance between synthesis and degradation of the components of the ECM of tendons. Figure 1 is a 
summary highlighting some of the proposed biological relationships between these ECM components in 
mechanically loaded tendons (September et al., 2011). In the event of mechanical loading, cell-signalling 
molecules such as IL-1β and IL-6 are up-regulated (Tsuzaki et al., 2003). Cytokines such as the 
interleukins form part of the inflammatory response (Tsuzaki et al., 2003), and it has been noted that 
early inflammation potentially plays a role in the aetiology of ATP (Scott, Backman, & Speed, 2015). 
Increased adiposity has been highlighted as a risk factor for ATP (Gaida, Ashe, Bass, & Cook, 2009) and 
evidence is mounting to suggest that a mechanism for this may be due to increased adiposity producing 
higher levels of circulating interleukins (Fain, 2006). Moreover, there is evidence to suggest that IL-1β 
and IL-6 variants, including IL-6 rs1800795 have  been  implicated  in the regulation of general adiposity 
(Strandberg et al., 2008). 
 
Furthermore, IL-1β and IL-6 stimulate downstream apoptotic mediators, including CASP-8, activating the 
apoptotic signalling cascade (Millar, Wei, Molloy, Bonar, & Murrell, 2009; Nell et al., 2012). This is a 
normal healing process (Nell et al., 2012) and the cell’s defence mechanism when tendons experience 
mechanical strain (Millar et al., 2009; Nell et al., 2012). In addition to these apoptotic mediators, matrix 
degrading enzymes (Sun et al., 2008; Thampattya, Li, Im, & Wang, 2007; Tsuzaki et al., 2003) and 
molecules, which alter COL5A1 expression are stimulated (Kahai, Vary, Gao, & Seth, 2004; Villiger, 
Kusari, ten Dijke, & Lotz, 1993). The downstream effects culminate in tenocyte apoptosis (Nell et al., 
2012), type V collagen degradation (Birkedal-Hansen et al., 1993) and increased COL5A1 gene 
expression, which collectively influence tendon capacity and most likely ATP susceptibility (Nell et al., 
2012). Identification of genetic sequence variants, which influence the regulation of the synthesis and 








Figure 1. Summary of some of the interdependent relationships between ECM components in mechanically 
loaded tendons and their potential effect on the risk of ATP development. IL-1β and IL-6 are induced by increased 
mechanical loading (Nell et al., 2012; Tsuzaki et al., 2003). IL-1β further up-regulates its own expression and 
activates MMPs, resulting in ECM degradation (Sun et al., 2008; Thampattya et al., 2007; Tsuzaki et al., 2003), 
including that of type V collagen(Birkedal-Hansen et al., 1993). IL-6 which is further up-regulated by IL-1β 
(Tsuzaki et al., 2003) can increase COL5A1 gene expression but primarily operates in the apoptosis signalling 
pathway. In this pathway, increased IL-6 expression further induces the production of ROS resulting in synthesis 
of the apoptotic mediator CASP-8 (Millar et al., 2009; September et al., 2011) and increased tenocyte apoptosis 
(Nell et al., 2012). Type V collagen degradation, increased COL5A1 gene expression and tenocyte apoptosis 
may all increase the risk of ATP (September et al., 2011). MIR608 which regulates type V collagen production 
(Abrahams et al., 2013) is also shown. The molecules and genes investigated in this study are shown in bold. 
The upwards arrows indicate increased expression. IL-1β: interleukin-1β, IL-6 interleukin-6, MMPs: matrix 
metalloproteinases, TGF-β: transforming growth factor β, ROS: reactive oxygen species, CASP8: caspase-
8, ATP: Achilles tendon pathology. 
 
Several sequence variants within COL5A1 (Mokone, Schwellnus, Noakes, & Collins, 2006; September et 
al., 2009), MIR608 (Abrahams et al., 2013), IL-1B, IL-6 (September et al., 2011) and CASP8 (Nell et al., 
2012) have been explored in South African and Australian study participants and require further validation in 
independent populations (Chanock et al., 2007; Collins et al., 2015). The aims of this study were therefore 
to evaluate COL5A1 rs12722 (C/T), COL5A1 rs3196378 (C/ A), COL5A1 rs71746744 (insertion/deletion), 
MIR608 rs4919510 (C/G), IL-1β rs16944 (C/T), IL-6 rs1800795 (G/C) as well as CASP8 rs1045485 (G/C) 
and CASP8 rs3834129 (insertion/deletion) for independent and collective associations with ATP in a British 
cohort. 
 
The a priori hypothesis was that (i) the COL5A1 rs3196378 C allele (September et al., 2009) the COL5A1 
rs71746744 insertion allele (Abrahams et al., 2013), the MIR608 rs4919510 CC genotype (Abrahams et al., 
2013), the IL-1β rs16944 C allele (September et al., 2011) and the IL-6 rs1800795 G allele (September et 
al., 2011) would be associated with an increased of risk of ATP, (ii) the COL5A1 rs12722 CC genotype 
(September et al., 2009), the CASP8 rs1045485 C allele (Nell et al., 2012) and the CASP8 rs3834129 
deletion allele (Nell et al., 2012) would be associated with a decreased risk of ATP and (iii) that the following 
inferred allele combinations would be associated with an increased risk of ATP: T–C–I (COL5A1: rs12722–
rs3196378–rs71746744) (Abrahams et al., 2013; September et al., 2009); A–C (COL5A1 rs3196378– 
MIR608 rs4919510) (Abrahams et al., 2013); C–G–T (IL-1β 
rs16944–IL-6 rs1800795–COL5A1 rs12722) (September et al., 2011) and I–G (CASP8: rs3834129–






A case-control genetic association study was employed, and the reporting of this study is in accordance with 
the STREGA initiative recommendations (Little et al., 2009); an extension of the STROBE statement (Von 
Elm et al., 2007).  During the period of June 2011 to June 2014, 267 British participants were recruited. The 
participants consisted of a control group (CON group) comprising 130 apparently healthy individuals and an 
ATP group (n = 112) comprising of 87 and 25 individuals diagnosed with (TEN sub-group) and (RUP 
subgroup) respectively 
 
These participants were previously recruited and described by Rickaby et al. (Rickaby, El Khoury, Ribbans, 
& Raleigh, 2015). All participants in the CON group and the ATP group were recruited from the same 
geographical area within the East Midlands region of the United Kingdom. In addition, the CON and ATP 
groups were matched for age and level of physical activity, at recruitment.  After recruitment, 25 individuals 
were excluded based on the inclusion and exclusion criteria described by Mokone et al. (2005, 2006). 
Participants who had used fluoroquinolone antibiotics (two exclusions) or local corticosteroid injections (two 
exclusions) into the Achilles tendon or surrounding structures prior to experiencing symptoms were 
excluded. This was necessary as fluoroquinolone antibiotics and corticosteroids increase the risk of RUPs 
(Newnham, Douglas, Legge, & Friend, 1991; Van der Linden et al., 2001). In addition, participants 
diagnosed with connective tissue disorders or systemic diseases possibly linked to ATP were excluded (15 
exclusions) (Mokone et al., 2006) together with 3 non-Caucasian 
 
participants and 3 participants originally recruited for the CON group who subsequently developed an injury. 
The TEN sub-group experienced gradual progressive pain in the area of the Achilles tendon for more than 6 
months accompanied by at least one of the following Achilles tendon symptoms: (1) early morning pain, (2) 
early morning stiffness, 
(3) swelling, (4) tenderness to palpation, (5) palpable nodular thickening or (6) movement of the painful 
region with plantardorsi-flexion (positive “shift” test) (Mokone et al., 2005, 2006). Individuals in the TEN sub-
group were diagnosed with insertional (n = 25) or non-insertional tendinopathy (n = 48) and in addition, 
some individuals presented with both insertional and non-insertional tendinopathies (n = 14). All clinical 
diagnoses of tendinopathy were confirmed by an ultrasound or magnetic resonance imaging (MRI). 
Individuals in the RUP sub-group were diagnosed with complete (n = 18) or partial ruptures (n = 7). All 
clinical diagnoses of ruptures were confirmed at the time of surgery or by imaging. Nine individuals who 
sustained RUPs were also diagnosed with tendinopathy but for the purpose of analyses were included in the 
RUP sub-group. 
All of the participants were of self-reported British Caucasian ancestry and signed written informed consent 
according to the Declaration of Helsinki. Questionnaires regarding physical activity details, injury details and 
medical history were also completed by each participant. Ethical approval for this study was obtained from 
the Human Research Ethics Committee of the Faculty of Health Sciences, University of Cape Town 
(reference number 370/2013) and the Research Ethics Committee of the University of Northampton. 
 
DNA extraction 
Approximately 2 ml of saliva was collected from each participant for the DNA extraction as previously 
described, using the ORAGENE DNA kits (OG-500) and the prepIT-L2P DNA extraction kit (DNA Genotek 
Inc., ON, Canada), which yielded A260/ 280 ratios between: 1.8 and 2.0 (Rickaby et al., 2015). All DNA 
extractions were conducted at the University of Northampton and made available for this study. 
 
Polymorphism analysis and genotyping 
All eight polymorphisms investigated in this study were previously implicated in ATP (Abrahams et al., 2013; 
Nell et al., 2012; September et al., 2009, 2011) and their minor allele frequencies are noted in 
supplementary Table 1. Polymorphisms included three single nucleotide polymorphisms (SNPs) and a short 
tandem repeat (STR) within two genes proposed to influence collagen fibril formation [COL5A1 rs12722 
(C/T), COL5A1 rs71746744 (insertion/deletion), COL5A1 rs3196378 (C/A), and MIR608 rs4919510 (C/G)] 
as 
well as three SNPs and a STR within three genes involved in the cell-signalling and apoptosis pathways [IL-
1β rs16944 (C/T), IL-6 rs1800795 (G/C), CASP8 rs1045485 (G/C) and CASP8 
rs3834129 (insertion/deletion)]. Moreover, the specific polymorphisms selected have been implicated to be 
of functional significance or have been localized to a region that is of functional significance in  the  aetiology  
of  ATP  (Abrahams et al., 2013; Nell et al., 2012; September et al., 2009, 2011). 
 
All participants were genotyped for these polymorphisms using one of two methods. The TaqManTM allelic 
discrimination assay (Applied Biosystems, Foster City, CA, USA) was used to genotype COL5A1 
rs3196378, COL5A1 rs71746744, MIR608 
rs4919510, CASP8 rs1045485 and CASP8 rs3834129. In this case the Applied Biosystems StepOnePlus™ 
Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) and the Applied Biosystems 
StepOnePlus™ Real-Time PCR software v2.2.2. (Applied Biosystems, Foster City, CA, USA) were used for 
polymerase chain reaction (PCR) reactions and genotype determination according to manufacturer’s 
recommendations. Standard PCR-based restriction fragment length polymorphism (RFLP) analysis was 
used to genotype COL5A1 rs12722 (BstUI), IL-1β rs16944 (AvaI) and IL-6 rs1800795 (Nlalll) as previously 
described (Mokone et al., 2006; September et al., 2011). After enzymatic digestion of the PCR amplicons, 
COL5A1 rs12722 restriction fragments were resolved on 6% polyacrylamide gels while IL-1β rs16944 and 
IL-6 rs1800795 restriction fragments were resolved on 2% agarose gels. Digestion of the 667bp COL5A1 
amplicon produced 316bp, 271bp and 80bp fragments for the C allele and 351bp and 316bp fragments for 
the T allele. Digestion of the 304bp IL-1β amplicon produced a 304bp fragment for the T allele and 190bp 
and 114bp fragments for the C allele. Digestion of the 228bp IL-6 amplicon produced 172bp and 56bp 
fragments for the G allele and 123bp, 56bp and 49bp fragments for the C allele. All restriction fragments 
were resolved alongside a 100bp size standard (Promega Corporation, Madison, WI, USA) along with an 
undigested PCR product, and samples with known genotypes. Products were visualized under ultraviolet 
light with the SYBR® Gold Nucleic Acid Gel Stain (Invitrogen Molecular Probes, OR, USA). In addition, each 
PCR plate (TaqManTM and RFLP) contained samples with known genotypes and samples with no DNA to 
ensure consistent genotyping and detect potential contamination. To avoid genotyping errors, samples that 
failed twice to amplify during PCR were considered as unsuccessfully genotyped and no further attempts 
were made to genotype them at that polymorphism locus. Samples that consistently failed to amplify during 
PCR were excluded in further studies. All genotype analyses were confirmed by two independent 
researchers and conducted at the Division of Exercise Science and Sports Medicine, Department of Human 
Biology, University of Cape Town or at the University of Northampton, UK. 
 
Statistical analysis 
Statistical power calculations were  previously  calculated using  Quanto  v1.2.   (http://hydra.usc.edu/gxe)   
(Rickaby et al., 2015).  STATISTICA v12 (StatSoft Inc., Tulsa, OK, USA) was used to compare basic 
participant characteristics of the study groups using a one way analysis of variance (ANOVA). The 
programming environment R (R Development Core Team, 2013) and R package, SNPassoc (González et  
al., 2007), was used to calculate and analyse  genotype  frequency distributions and for Hardy–Weinberg 
Equilibrium probabilities while the R package, Haplo.stats, (Sinnwell & Schaid, 2008) was used to analyse 
inferred allele combinations. GraphPad Prism v5.02 was used to analyse allele 
 
frequency distributions. All genotype and allele frequency distributions were analysed using Pearson’s chi-
squared analyses (χ2) or Fisher’s exact tests. Regarding genotype frequencies, global P-values were 
initially analysed followed by P-values for dominant, recessive and  over-dominant models if significance or 
trends towards significance were observed as our study was based on an a priori hypothesis. Similarly, for 
inferred allele combinations, global P-values for additive, dominant and recessive models were analysed 
followed by  P-values  for  each  allele  combination  within the different models. In all instances, the lowest 
P-value indicates the best fit model and  these  are  the  P-values which are reported. Significance was 
accepted at P < 0.05 for all analyses. Information regarding basic participant characteristics was not 
available for all participants; therefore, analyses were conducted without adjusting for covariates and without 





The CON and ATP groups as well as the CON group and RUP sub-group were similarly matched for age, 
height, weight, BMI, sex and country of birth (Table 1). The CON group and the TEN sub-group were 
similarly matched for all characteristics except age (P = 0.044) where the CON group participants were 
significantly younger at age of recruitment than the TEN subgroup participants were at age of initial onset of 
symptoms. There were no significant genotype effects on any of the participant characteristics (data not 
shown) except for COL5A1 rs12722 (C/T) and IL-6 rs1800795 (G/C), which showed significant effects on 
BMI (P = 0.027) and sex (P = 0.046), respectively. On average, individuals with a COL5A1 rs12722 TT 
genotype had a significantly lower BMI than individuals with a CT genotype (P = 0.019) (TT: 24.7 ± 4.34 
kg/m2; CT: 
26.69 ± 4.25 kg/m2) and in addition there were significantly more males than females with the IL-6 
rs1800795 GG genotype (P = 0.014). Both the CON and ATP groups were similarly grouped for levels of 
vigorous physical activity as defined by Haskell et al.(Haskell et al., 2007). Mean values (hours/week) were 
4.46 ± 4.24 for the CON group and 4.19 ± 3.73 for the ATP group. No significant differences (P > 0.05) 
between these values were noted. 
 
Genotype and allele frequencies 
There were no independent significant differences in the genotype or allele frequency distributions between 
any of the groups for the three COL5A1 variants (Table 2). MIR608 rs4919510 and IL-1B rs16944 showed 
no significant differences in genotype or allele frequency distributions between the CON and ATP groups or 
between the CON group and TEN subgroup. There were, however, significant differences in genotype 
distributions between the CON group and the RUP subgroup (Table 2). The CG genotype of MIR608 
rs4919510 was significantly associated with a decreased risk of RUP (overdominant model: P = 0.022, odds 
ratio [OR]: 0.30, 95% confidence interval [CI]: 0.10–0.93). The CT genotype of IL-1β rs16944 was 
significantly associated with an increased risk of RUP (over-dominant model: P = 0.012, OR: 3.96, 95% CI: 
1.24– 12.70). These findings should, however, be interpreted with caution owing to the sample size 
limitation of the RUP subgroup. IL-6 rs1800795 and CASP8 rs1045485 showed no significant differences in 
genotype or allele frequency distributions between any of the groups (Table 2). CASP8 rs3834129 also 
showed no significant differences in genotype or allele frequencies but a trend suggesting differing genotype 
distributions between the CON group and TEN sub-group was observed (P = 0.060). Further analyses 
following the a priori hypothesis indicated that the DD genotype was significantly associated with a 
decreased risk of TEN (recessive model: P = 0.020, OR: 0.45, 95% CI: 0.22–0.90). The genotype 
distributions of all the groups were in Hardy–Weinberg equilibrium except for the RUP sub-groups of 
COL5A1 rs12722 and IL-1β rs16944 (Table 2). 
 
 
Inferred allele combinations 
Inferred allele combinations were constructed from COL5A1 rs12722, rs3196378 and rs71746744 with six 
possible combinations noted [Figure 2(a)]. The T–A–I inferred allele combination was the most common 
(overall frequency: 45%) while the T–C–I and T–C–D inferred allele combinations were the least common 
(overall frequency: 3%). Global P-values revealed that the COL5A1 inferred allele combinations associated 
with the risk of ATP (additive and dominant models: P = 0.003) and RUP (additive and dominant models: P 
< 0.001). It was interesting to note that global P-values approached significance when the CON group and 




Table 1. Participant characteristics of the control group (CON), Achilles tendon pathology group (ATP), Achilles 
tendinopathy sub-group (TEN) and Achilles tendon rupture sub-group (RUP). 
 CON (n = 
130) 















Age (years) 41.6 ± 11.6 
(123) 
43.9 ± 13.8 
(112) 
0.167 45.2 ± 14.4 
(87) 




Height (cm) 174.9 ± 10.4 
(123) 
172.8 ± 9.2 
(109) 
0.101 172.3 ± 8.5 
(84) 




Weight (kg) 80.2 ± 19.5 
(124) 
77.7 ± 15.0 
(82) 
0.324 77.1 ± 15.0 
(62) 




BMI (kg/m2) 25.9 ± 4.5 26.0 ± 4.0 0.877 25.9 ± 4.1 0.983 26.4 ± 3.9 0.68
(123) (82) (62) (20) 4 
Sex (%male) 63.1 (82) 60.7 (68) 0.706 58.6 (51) 0.509 68.0 (17) 0.63
9 
Country of birth 
(%UK) 
96.0 (119) 94.6 (105) 0.619 95.4 (83) 0.840 88.0 (22) 0.10
7 
Note: Age, weight and BMI values are self-reported values at the time of recruitment for the CON group and at 
initial onset of symptoms for the ATP group and the TEN and RUP sub-groups. All values for age, height, weight 
and BMI are expressed as the mean ± the standard deviation while values for sex and country of birth are 
expressed as percentages. Numbers in parenthesis indicate the number of participants (n). Values in bold 












Table 2. Genotype and minor allele frequency distributions as well as the calculated Hardy–Weinberg P-values 
for COL5A1 rs12722, COL5A1 rs3196378, COL5A1 rs71746744, MIR608 rs4919510, IL-1β rs16944, IL-6 
rs1800795, CASP8 rs1045485 and CASP8 rs3834129 in the control group (CON), Achilles tendon pathology 
group (ATP), Achilles tendinopathy sub-group (TEN) and Achilles tendon rupture sub-group (RUP). 
 CO



























104  82  22  
 CC 22 (27) 28 (29) 
0.683 24 
(20) 
0.852 32 (7) 0.10
8 
 CT 51 (64) 46 (48)  
51 
(42)  
27 (6)  
 TT 27 (34) 26 (27)  
24 
(20)  
41 (9)  
 T allele 53 (132) 49 (102) 
0.423 50 
(82) 
0.377 55 (24) 0.83
1 






108  84  24  
 CC 26 (32) 23 (25) 
0.719 23 
(19) 
0.823 25 (6) 0.55
4 
 AC 47 (58) 45 (49)  
48 
(40)  
38 (9)  
 AA 27 (33) 32 (34)  
30 
(25)  
38 (9)  
 A allele 50 (124) 54 (117) 
0.420 54 
(90) 
0.527 56 (27) 0.45
9 






108  85  23  
 II 41 (53) 50 (54) 
0.305 48 
(41) 
0.507 57 (13) 0.31
8 
 ID 52 (67) 42 (45)  
44 
(37)  
35 (8)  
 DD 8 (10) 8 (9)  8 (7)  9 (2)  
 D allele 33 (87) 29 (63) 
0.315 30 
(51) 
0.452 26 (12) 0.19
5 






110  85  25  
 CC 59 (73) 66 (73) 
0.145 64 
(54) 
0.441 76 (19) 0.046 
 CG 39 (48) 28 (31)  
32 
(27)  
16 (4)  
 GG 2 (3) 6 (6)  5 (4)  8 (2)  
 G allele 22 (54) 24 (53) 
0.551 21 
(35) 
0.771 16 (8) 0.35
9 
 HWE 0.187 0.358  0.745  
0.083  
IL-1β rs16944 (C/T) N 10
9 
91  72  19  
 CC 38 (41) 39 (35) 
0.532 43 
(31) 
0.728 21 (4) 0.041 
 CT 49 (53) 53 (48)  
46 
(33)  
79 (15)  
 TT 14 (15) 9 (8)  11 (8)  
0 (0)  
 T allele 38 (83) 35 (64) 
0.548 34 
(49) 
0.434 39 (15) 0.87
0 






90  71  19  
 GG 28 (31) 31 (28) 
0.746 27 
(19) 
0.867 47 (9) 0.21
4 
 GC 50 (54) 51 (46)  
54 
(38)  
42 (8)  
 CC 22 (24) 18 (16)  
20 
(14)  
11 (2)  
 C allele 47 (10) 43 (78) 
0.491 47 
(66) 
0.954 32 (12) 0.08
2 






104  80  24  
 GG 80 (93) 82 (85) 
0.649 81 
(65) 
0.686 83 (20) 1.00
0 
 GC 19 (22) 18 (19)  
19 
(15)  
17 (4)  
 CC 2 (2) 0 (0)  0 (0)  0 (0)  
 C allele 11 (26) 9 (19) 0.493 9 (15) 
0.579 8 (4) 0.57
0 






107  84  23  
 DD 29 (37) 19 (20) 
0.159 15 
(13) 
0.060 30 (7) 0.97
5 
 DI 43 (54) 51 (55)  
54 
(45)  
44 (10)  
 II 28 (36) 30 (32)  
31 
(26)  
26 (6)  
 I allele 50 (126) 56 (119) 
0.195 57 
(97) 
0.101 48 (22) 0.82
4 
 HWE 0.110 0.845  0.50
2 
 0.676  
Notes: Genotype and allele frequencies are expressed as percentages with the number of participants shown 
in parenthesis (n). Global P-values are given with bold typeset indicating significant differences (P < 0.05). 








model: P = 0.053). More specifically, the T–C–D combination was found to increase the risk of ATP (additive 
and dominant models: P = 0.023) and RUP (additive and dominant models: P < 0.000) while the C–A–I 
combination was found to increase the risk of ATP (additive model: P = 0.011), TEN (dominant model: P = 
0.011) and RUP (additive model: P = 0.011). Alternatively, the C–C–D combination was associated with a 
decreased risk of ATP (dominant model: P = 0.011) and RUP (dominant: P = 0.004). 
Four possible inferred allele combinations were constructed from COL5A1 rs3196378 and MIR608 
rs4919510 
 
[Figure 2(b)]. The A–C inferred allele combination was the most common (overall frequency: 40%) whereas 
the C–G inferred allele combination was the least common (overall frequency: 8%). None of the 
combinations were significantly associated with the risk of ATP. 
Inferred allele combinations were constructed from IL-1β rs16944, IL-6 rs1800795 and COL5A1 rs12722 
[Figure 2(c)]. Eight possible combinations that were all similar in range were noted. These eight 
combinations were equally distributed amongst the cases and controls with no combinations significantly 






Figure 2. Frequency distributions of the inferred allele combinations for: (a) COL5A1 rs12722, rs3196378 
and rs71746744, (b) COL5A1 rs3196378 and MIR608 rs4919510, (c) IL-1β rs16944, IL-6 rs1800795 and 
COL5A1 rs12722 and (d) CASP8 rs3834129 and rs1045485 in the CON group (white bars), ATP group 
(checked bars), TEN sub-group (black bars) and RUP sub-group (grey bars). An asterisk indicates a 
significant difference between groups (P < 0.05). The number of individuals in each group is shown in 
parenthesis (n). 
 
Four possible inferred allele combinations were constructed from CASP8 rs3834129 and rs1045485 [Figure 
2(d)]. D–G and I–G were identified as the two major combinations while D–C and I–C were the two minor 
combinations. I–G was the most common inferred allele combination (overall frequency: 50%) whereas I–C 
was the least common (overall frequency: 3%). Global P-values were not significant for any of the groups; 
however, considering the a priori hypothesis, significance was observed when P-values for the individual 
inferred allele combinations were analysed. The I–G combination was significantly associated with an 
increased risk of TEN (dominant model P = 0.031). 
 
Discussion 
ATP is a multifactorial condition for which a genetic component has been identified (Collins et al., 2015). To 
date, several specific loci have been associated with risk in independent populations of South African and 
Australian ancestry. As such, the aim of this study was to evaluate eight previously identified predisposing 
genetic variants in a third population. Overall, the findings from this association study further support the 
hypothesis that genetic sequences influencing regulation of the synthesis and degradation of the ECM of 
tendons may play an important role in modulating risk of ATP. The main findings of this study included (i) 
the associations of the COL5A1 inferred allele combinations with the risk of all three phenotypes and (ii) the 
independent and collective associations of CASP8 with the risk of TEN. In addition, MIR608 and IL1B were 
independently associated with the risk of RUPs, however, as previously highlighted these findings should be 
interpreted with caution. 
 
The COL5A1 3ʹUTR has been extensively studied in the aetiology of ATP with multiple sequence variants 
both independently and collectively noted as risk modifiers (Abrahams et al., 2013; Mokone et al., 2006; 
September et al., 2009). The inferred allele combinations identified in this study were constructed from three 
variants situated within the COL5A1 3ʹUTR. Our findings were in partial agreement with published literature 
and our a priori hypothesis. The T–C (COL5A1 rs12722– rs3196378) inferred allele combination and the 
COL5A1 rs71746744 II genotype were previously associated with an increased risk of TEN (Abrahams et 
al., 2013; September et al., 2009). The a priori hypothesis thus included that the T–C–I inferred allele 
combination increases the risk of ATP in the British cohort. In the current study, three risk modifying inferred 
allele combinations were detected. Specifically, the T– C–D and C–A–I combinations were associated with 
an increased risk of ATP while the C–C–D combination was associated with a decreased risk of ATP. 
Interestingly, the three alleles in the C–C–D inferred allele combination were identified in the major 
functional form of the COL5A1 3ʹUTR previously proposed to be associated with reduced risk of chronic 
TEN (Collins & Posthumus, 2011; Laguette, Abrahams, Prince, & Collins, 2011). To date, no study has 
analysed COL5A1 rs127277, rs3196378 and rs71746744 in an inferred allele combination, hence further 
analyses in additional independent populations are recommended. Nonetheless, this study was able to 
further implicate variants within the COL5A1 3ʹUTR in the aetiology of ATP in a third study group, composed 
of participants of self-reported British ancestry. 
 
Biologically, polymorphisms within the 3ʹUTR could affect the 3ʹUTR secondary structure (Abrahams et al., 
2013). This may cause alterations in COL5A1 mRNA stability and subsequently the production of the α1 
chain of type V collagen (α1 (V)) (Abrahams et al., 2013). We have previously identified two functional forms 
of the COL5A1 3ʹUTR, namely the Cand T-functional forms, with the C-functional form having decreased 
mRNA stability compared to the T-form (Laguette et al., 2011). Based on its function and the previous 
association 
 
of variants within the 3ʹUTR with altered risk of TEN, the C-functional form has been proposed to reduce the 
risk of TEN (Collins & Posthumus, 2011). As previously mentioned, the three alleles in the C–C–D inferred 
combination which associated with reduced ATP risk in this study were identified in the C-functional form of 
the COL5A1 3ʹUTR. Moreover, COL5A1 rs3196378 is located within a Hsa-miR-608 binding site, which 
Laguette et al. have shown to be functional (Laguette et al., 2011). Since microRNA molecules are involved 
in gene regulation (He & Hannon, 2004), differential miRNA binding may also influence the production of 
α1(V) (Abrahams et al., 2013). These small changes in COL5A1 translation may lead to interindividual 
variation in fibrillogenesis and predisposition to ATP (Collins & Posthumus, 2011). 
 
The second main finding of this study implicated CASP8. Individuals with a CASP8 rs3834129 DD genotype 
were at a 55% reduced risk of developing TEN. In addition, individuals with the CASP8 I–G (rs3834129–
rs1045485) inferred allele combination were at an increased risk of developing TEN. Both of these findings 
are in line with the a priori hypothesis. Nell et al. have reported that the CASP8 rs3834129 DD genotype 
increases the risk of TEN whereas the ID genotype decreases the risk of TEN (Nell et al., 2012). Nell et al. 
also found that the D–C inferred allele combination decreases the risk of TEN (Nell et al., 2012). The 
independent genotype association found in this study is in contrast to the findings of Nell et al. but makes 
biological sense. 
 
The D allele of CASP8 rs3834129 causes destruction of an Sp1 binding element, resulting in decreased 
gene expression and reduced levels of caspase-8 protein (Sun et al., 2007). This could prevent excessive 
apoptosis and protect against TEN (Nell et al., 2012). The inferred allele combination association found in 
this study is in agreement with previous findings and is also biologically plausible. Since the D allele of 
CASP8 rs384129 is protective, the I allele is expected to be deleterious. Furthermore, the G allele of CASP8 
rs1045485 encodes the wild-type Asp amino acid which is predicted to result in a more stable form of the 
caspase-8 protein (MacPherson et al., 2004). This promotes apoptosis and may increase the risk of TEN 
(Nell et al., 2012). Rickaby et al. recently showed that a CASP8 copy number variant, spanning intron 11-
intron 12, which overlaps CASP8 rs1045485 and is approximately 50000bp from rs3834129, is not 
associated with ATP in the same British cohort (Rickaby et al., 2015). They subsequently speculated that 
associations of the CASP8 locus with ATP may be population specific and recommended that the CASP8 
variants investigated by Nell et al. (2012) were tested in a British cohort. The current study evaluated these 
previously studied variants and revealed that the CASP8 locus is also associated with the risk of ATP in an 
independent British population. However, more samples are required to be investigated at this locus to allow 
for conclusive evidence. 
 
The additional findings concerning MIR608 rs4919510 and IL1B rs16944 suggested that (i) individuals with 
a MIR608 rs4919510 CG genotype were at a 70% reduced risk of developing RUPs compared to individuals 
with CC or GG genotypes and (ii) individuals with an IL-1B rs16944 CT genotype were 3.96 times more 
likely to develop RUPs than individuals with CC or TT genotypes. These findings are novel since no study 
has found associations between these SNPs and the risk of only RUPs, however, because the RUP sub-
group was small, replication in larger study participant groups is crucial for added credibility. 
This study was not able to replicate the independent associations of COL5A1 rs12722, COL5A1 rs3196378, 
COL5A1 rs71746744 or MIR608 rs4919510 with the risk of TEN. Nor were we able to replicate the collective 
associations of COL5AI–MIR608 or IL–6–IL-1B–COL5A1 with the risk of TEN. This may be reflective of the 
study limitations. The main limitation was the small sample size, resulting in reduced power when analysing 
the TEN and RUP sub-groups separately. As such, the findings pertaining to these groups need to be 
interpreted cautiously, particularly regarding the RUP sub-group (n = 25). Second, statistical analyses were 
conducted without adjusting for possible confounding variables. This presented a limitation when the CON 
group and TEN sub-group were analysed because participants in the CON group were significantly younger 
than participants in the TEN sub-group. A third potential limitation was the COL5A1 rs12722 and IL-6 
rs1800795 genotype–BMI and genotype– sex associations, respectively. Similar genetic studies in larger 
cohorts did not, however, report any genotype–BMI or genotype–sex associations for these variants 
(Mokone et al., 2006; September et al., 2009, 2011). In view of the fact that this study is influenced by the 
small sample size; to fully comprehend the involvement of these loci in the aetiology of ATP, it is 
recommended that this study is repeated in a larger study group. Finally, the different pathology phenotypes 
in the TEN and RUP sub-groups was a potential limitation. The TEN sub-group consisted of individuals 
diagnosed with insertional and non-insertional tendinopathy while the RUP sub-group consisted of 
individuals diagnosed with complete and partial ruptures. Furthermore, combining the TEN and RUP sub-
groups into the ATP group resulted in the grouping of chronic and acute   pathologies. The   possibility of 
different injury mechanisms in these groups cannot be excluded. 
 
The major difference between the current study and previous studies is the investigation of these eight 
variants in an association study with RUP risk. There is evidence to suggest that the incidence of acute 
RUPs is increasing and the exact mechanism underlying this increase remains to be explored (Huttunen, 
Kannus, Rolf, Fellander-Tsai, & Mattila, 2014; Lantto, Heikkinen, Flinkkilä, Ohtonen, & Leppilahti, 2015). To 
increase our understanding of these eight functional variants and the risk of ATP, it is important that they are 
investigated in chronic and acute injuries. It is, therefore, necessary to understand the differences between 
the incidences of ATP in various populations. However, there is currently limited published epidemiological 
data for effective comparison. 
 
In conclusion, this study further highlights the importance of polymorphisms within the COL5A1 and CASP8 
genes in the aetiology of ATP. In addition, the potential role of the MIR608 and IL-1β variants was reiterated 
but only within the small RUP sub-group. It would, therefore, be beneficial to repeat this genetic association 
study in a larger British cohort. Finally, genetic sequencing will play a pivotal role in expediting the 
identification of sequence variants which affect susceptibility to ATP and will contribute to broadening our 
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